For years, Christopher P. Austin - a world class medical scientist has been trying to develop a way for science to build a better partnership with patients.Dr. Austin is the director of the National Center for Advancing
Translational Sciences (NCATS), part of the NIH Baltimore maryland USA. NCATS is trying to find
ways to get new treatments and cures for diseases delivered to patients
faster.
At NCATS, Dr. Austin heads a state-of-the-art lab that uses robots to search for treatments.
In recent years, families of patients with rare diseases have made
their way to the NIH to watch the robots at work in the $20 million,
30,000 square-foot system that includes refrigerators, automated
incubators and computers. Machines work around-the-clock, testing
hundreds of thousands of compounds against a variety of mostly rare
diseases.
One of the first parents to visit was a woman whose college-age son
had a rare cancer. During a tour in 2006, Dr. Austin told her that
instead of 17 years to develop a new drug, he hoped that the lab could
cut the time to 10 years.
“ ‘I love your technology,’ ’’ Dr. Austin recalled the woman saying.
“ ‘I love your robots. I love this fancy stuff. But for my child and
this disease, 10 years, 15 years, isn’t going to work. Isn’t there
something else we can do?’ ’’
It is a question he hears again and again. There are roughly 7,000
known diseases; only about 500 have a treatment. Even with robots
working day and night, Dr. Austin said, the arithmetic is discouraging.
Dr. Austin and the Journal’s Amy Dockser Marcus will answer readers’ questions about rare diseases and the research process. They will host a Reddit AMA (short for “Ask Me Anything) at 1 p.m. ET on Wednesday, December 4.
0 comments:
Post a Comment